Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
Heron Therapeutics, Inc. (Nasdaq: HRTX) will participate in a fireside chat at the 42nd Annual Cowen Healthcare Conference on March 7, 2022, at 11:10 am PT. The live webcast will be accessible on their website in the Investor Resources section. As a commercial-stage biotechnology company, Heron focuses on developing innovative treatments for unmet patient needs in acute care and oncology. Their advanced science and patented technologies have led to a unique portfolio aimed at enhancing standards of care. More information is available at www.herontx.com.
- None.
- None.
SAN DIEGO, March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that company management will participate in a fireside chat at the 42nd Annual Cowen Healthcare Conference on Monday, March 7, 2022 at 11:10 am PT/2:10 pm ET.
A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447
View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-42nd-annual-cowen-healthcare-conference-301494426.html
SOURCE Heron Therapeutics, Inc.
FAQ
When is Heron Therapeutics presenting at the Cowen Healthcare Conference?
How can I watch Heron Therapeutics' fireside chat?
What is Heron Therapeutics focused on?
What stock symbol is associated with Heron Therapeutics?
